1123 women received free breast cancer screening through Phakamisa at Kenyatta National Hospital in Kenya.
Phakamisa, our AstraZeneca-sponsored public access programme for Breast and Prostate Cancer, supported free breast and cervical cancer screening at Kenyatta National Hospital in Kenya in October. Clinical breast examinations were performed on both males and females attending the October Breast Cancer Awareness month cancer screening clinic and for those with indications, free mammograms were also provided. A total of 1123 people were screened over the two days.
The two-day screening event was by preceded by a one day Phakamisa workshop, where a multidisciplinary team of registrars and nurses were upskilled on the value of screening and screening guidelines. Professor Nicholas Anthony Othieno Abinya, a well-respected expert in the field of Oncology in Kenya staged the comprehensive training, including how to perform specific screening procedures: mammogram and clinical breast examination.
By raising awareness about the importance of screening and early detection of Breast Cancer amongst Kenyan residents, as well as the staff of Kenyatta National Hospital, we hope for better management and outcomes for the disease.
A huge thank you to the team in Kenya who were instrumental in ensuring the success of the event.
Through our commitment to initiatives like the Phakamisa event in Kenya, we are able to make a profound difference to those who have limited access to resources available for prevention, diagnosis and treatment of cancer
Activity ID: ZA-1665
Expiry Date: 31/12/2021
AstraZeneca Pharmaceuticals (Pty) Ltd. South Africa Reg. No. 1992/005854/07
Building 2, Northdowns Office Park, 17 Georgian Crescent West, Bryanston, 2191, South Africa
Private Bag X23, Bryanston, 2021, South Africa. Tel: +27(0) 11 797-6000. Fax: +27(0) 11 797-6001. www.astrazeneca.com.
Social media, review sites and other public internet sites are not the places for your comments and questions, however questions or comments can be answered by the AZ Medical Information Service at the following addresses: SA.MEAMedinfo@astrazeneca.com or call: +27 (0)11-797 6040/6174